MALVERN, Pa., Nov. 15, 2024 /CNW/ -- Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback